New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but

Updated on: March 29,2024

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

FEBRUARY 15, 2024byQueen Mary, University of LondonCredit: Pixabay/CC0 Public DomainAn innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but

Updated on:March 29,2024

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu

Updated on: December 25,2023

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu

Updated on:December 25,2023

New health mapping study pinpoints cancer risk factors at local level

byQueensland University of TechnologyThe maps show areas where unhealthy behaviors are more (marked in red) or less (in blue) common than the national average. The deeper the shade, the greater

Updated on: December 28,2023

New health mapping study pinpoints cancer risk factors at local level

byQueensland University of TechnologyThe maps show areas where unhealthy behaviors are more (marked in red) or less (in blue) common than the national average. The deeper the shade, the greater

Updated on:December 28,2023

Heterogeneity of liver cancer cells helps explain tumor progression in patients

byThe Mount Sinai HospitalCredit: CC0 Public DomainMany liver cancer tumors contain a highly diverse set of cells, a phenomenon known as intra-tumor heterogeneity that can significantly affect t

Updated on: December 20,2023

Heterogeneity of liver cancer cells helps explain tumor progression in patients

byThe Mount Sinai HospitalCredit: CC0 Public DomainMany liver cancer tumors contain a highly diverse set of cells, a phenomenon known as intra-tumor heterogeneity that can significantly affect t

Updated on:December 20,2023

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im

Updated on: March 25,2024

A new therapeutic target turns the immune system against lymphoma

by Ecole Polytechnique Federale de LausanneCredit: CC0 Public DomainNon-Hodgkin's lymphoma (NHL) is a group of cancers that originate in the lymph nodes and affect white blood cells of the im

Updated on:March 25,2024

Video animation guide to help young people living with cancer-related fatigue

byUniversity of BathCredit: University of BathA new resource has been launched by a team of psychologists at the University of Bath aiming to help young people living with cancer-related fatigue

Updated on: January 04,2024

Video animation guide to help young people living with cancer-related fatigue

byUniversity of BathCredit: University of BathA new resource has been launched by a team of psychologists at the University of Bath aiming to help young people living with cancer-related fatigue

Updated on:January 04,2024

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on: January 04,2024

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on:January 04,2024

The role of p53 as a target for novel cancer therapies

by Erika Rindsjö,Karolinska InstitutetComplex interplay between TP53-mutant cancer cells and their microenvironment. Credit:Nature Reviews Clinical Oncology(2023). DOI: 10.1038/s4157

Updated on: December 30,2023

The role of p53 as a target for novel cancer therapies

by Erika Rindsjö,Karolinska InstitutetComplex interplay between TP53-mutant cancer cells and their microenvironment. Credit:Nature Reviews Clinical Oncology(2023). DOI: 10.1038/s4157

Updated on:December 30,2023

Researchers map the effects of all potential changes in key cancer gene

byThe Francis Crick InstituteFunction scores capture fitness effects mediated at both the transcript and protein 457 level. Credit: Megan Buckley et alResearchers at the Francis Crick Institute

Updated on: July 06,2024

Researchers map the effects of all potential changes in key cancer gene

byThe Francis Crick InstituteFunction scores capture fitness effects mediated at both the transcript and protein 457 level. Credit: Megan Buckley et alResearchers at the Francis Crick Institute

Updated on:July 06,2024

What is the breast cancer risk calculator recommended by Olivia Munn?

by Carla K. JohnsonOlivia Munn arrives at the Governors Awards on Tuesday, Jan. 9, 2024, at the Dolby Ballroom in Los Angeles. When Munn revealed in March 2024 that she was diagnosed with breast cance

Updated on: March 20,2024

What is the breast cancer risk calculator recommended by Olivia Munn?

by Carla K. JohnsonOlivia Munn arrives at the Governors Awards on Tuesday, Jan. 9, 2024, at the Dolby Ballroom in Los Angeles. When Munn revealed in March 2024 that she was diagnosed with breast cance

Updated on:March 20,2024

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204

Updated on: January 30,2024

Billions spent on cancer research but only small percentage goes to treatment, study shows

by University of SouthamptonFunding per year by type of science (A) and proportion of funding per year by type of science (B). Credit:The Lancet Oncology(2023). DOI: 10.1016/S1470-204

Updated on:January 30,2024

Lower prostate cancer screening rates associated with subsequent increase in advanced cancers

byAmerican Society for Radiation OncologyProstate cancer cells. Credit: NIH Image GalleryIn the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a

Updated on: December 26,2023

Lower prostate cancer screening rates associated with subsequent increase in advanced cancers

byAmerican Society for Radiation OncologyProstate cancer cells. Credit: NIH Image GalleryIn the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings, a

Updated on:December 26,2023